Can You Build a Tolerance to Mounjaro? (October 2026)

01 · The core answer

Do you build a tolerance to Mounjaro?

What people usually describe as tolerance is one of three separate things: side effects easing as the body adjusts, appetite feeling less suppressed than it did at the start, or weight loss slowing down. Each has different explanations and a different next step.

Mounjaro (tirzepatide) activates two natural gut-hormone receptors at once, GIP and GLP-1, which help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹ If the medicine feels weaker, talk to your prescriber rather than changing the dose yourself.

If you are reading this because the medicine feels weaker, our guides on how Mounjaro tolerance is discussed and tolerance to GLP-1 medicines in general go through the same question from other angles.

02 · Your next step

What to do if Mounjaro seems to have stopped working

Start by writing down what has actually changed, because the right response depends on the answer. Is it appetite, the scale, side effects, or simply how you feel about the treatment? Then note your current dose, when you last increased it, and whether any injections were late or missed. That short record makes a review far more useful.

Next, speak to the prescriber who looks after your treatment. At EverydayMeds, ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team are part of the service, so a concern about reduced effect is exactly what those reviews are for.

If you are not yet a patient and want a clinician to look at your situation, the Mounjaro pen consultation is free. Our wider weight loss clinic page explains the full pathway.

Related guides: Can you build up a tolerance to mounjaro and Does mounjaro build up in your system.

03 · How Mounjaro works

How Mounjaro works, and why that matters for tolerance

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹

Tirzepatide activates both GIP and GLP-1 receptors. Together these help regulate appetite, slow how quickly the stomach empties and improve how the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

That dual action distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).¹ The practical point is that the effect on appetite depends on the medicine being in your system. It is not a switch that flips once and stays flipped.

If you notice your appetite effect changing, review it with your prescriber.

04 · Dose escalation and adjustment

Dose escalation: why the first weeks feel different

Treatment begins on the 2.5mg pen and the dose steps up after at least 4 weeks, through 5mg, 7.5mg, 10mg and 12.5mg, to a maximum of 15mg, depending on how you respond and tolerate it.

The pens come in these strengths because the dose is meant to rise gradually.¹ The starting dose is about letting your body adjust, not about weight loss itself.

Your prescriber will decide whether a step up, a hold or a step down fits your situation.

05 · Plateaus and slower loss

Can you plateau on Mounjaro?

Yes, a pause in weight loss can happen on Mounjaro, and it does not by itself mean the medicine has failed. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² An average hides a wide range of individual experiences, so your own line on the chart will not look like the headline figure, and a stall for a few weeks is not the same as a stopped treatment.

A useful way to think about a plateau is as a prompt to check the basics with a clinician. Useful questions include whether your dose is still the one you were prescribed, whether any injections were late, whether your eating pattern has drifted, and whether activity has changed.

If you are also curious about keeping muscle while you lose weight, our guides on building muscle during treatment and strength training on GLP-1 medicines cover that side of the question.

06 · Appetite returning

Why is Mounjaro no longer suppressing my appetite?

If your appetite feels stronger than it did, the first thing to do is tell your prescriber rather than assume the medicine has stopped working. The mechanism helps you feel fuller sooner and less hungry between meals, and it supports a reduced-calorie diet.¹ It does not remove choice, and it works best alongside the diet and activity changes that go with it.

There are several everyday reasons appetite can feel different, and none of them requires a theory about tolerance. The injection day may have slipped, so the gap between doses has stretched. Your routine may have changed, with different sleep, stress or meal patterns. Your dose may be lower than the one that suited you best, or you may be mid-titration where the medicine is still being built up. These are questions, not conclusions, and a review is the way to answer them.

It is also worth separating hunger from habit. Some people find the physical sense of hunger remains quiet while cravings tied to routine, boredom or particular foods are still present. A prescriber or dietitian can help with that, and the medicine is intended to be one part of a wider plan.

We would be wary of any website, forum thread or seller who tells you to change dose to chase a returning appetite. Dose stretching, extra injections and unlicensed combinations are unsafe and unlicensed. The only safe route is a review with the clinician responsible for your prescription.

07 · Breaks and restarting

Is it safe to restart Mounjaro after a break?

Whether it is safe to restart depends on how long you have been off and what dose you were on, and that is a decision for your prescriber. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

That slow clearance is one reason a short gap does not behave like a fresh start.

Before you inject again after a gap, contact your prescriber, tell them the date of your last dose and your last strength, and ask what they advise. At EverydayMeds, repeat orders re-check suitability and there is no auto-shipping, so a pause never leaves you with a pen arriving without a review.

Speak to your prescriber before restarting.

08 · Ozempic and Wegovy comparison

Does Ozempic eventually stop working?

Ozempic is semaglutide licensed for type 2 diabetes only; it is not a UK weight-loss medicine, and a change in effect is a reason for review with your prescriber. Semaglutide is a single-action GLP-1 medicine, whereas tirzepatide activates both GIP and GLP-1 receptors.¹

Wegovy, also semaglutide, is dosed once weekly on a ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after 4 weeks on each of 0.25mg, 0.5mg, 1mg and 1.7mg, so the 2.4mg maintenance dose starts from week 17. The 2.4mg dose is the licensed maintenance dose for weight management.¹⁸

People sometimes switch from one medicine to another when they feel the first has stopped doing enough. That is a clinical decision, and it should not be driven by online accounts or a guess about tolerance. If you are thinking about it, ask your prescriber what the options are and what the trade-offs look like.

09 · Evidence and individual variation

What the trial evidence does and does not tell you

The headline trial for weight management gives averages and proportions, not promises. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

Read those figures for what they are. They show that most participants lost a meaningful amount, and they also leave a minority who lost less. Trial averages do not predict your own result, and a slow patch in any one person can sit comfortably inside the range of outcomes the trial reports.

For a worked example of scale only: for someone starting at 100 kg, 20.9% is about 21 kg. That is arithmetic on a trial average, not a forecast.

10 · Safety and reporting

Safety, new symptoms and the Yellow Card scheme

If something new appears while you are on Mounjaro, tell your prescriber, and consider reporting it through the MHRA Yellow Card scheme.¹⁹ This applies to symptoms you did not expect, to side effects that return after settling, and to anything that worries you.

If a symptom is not on the Mounjaro patient leaflet list, it is not a listed side effect; tell your prescriber about any new or lasting symptom.¹³

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary, and this page is information, not a substitute for medical advice.

Be cautious about anyone offering to supply without a consultation or prescription, or promising specific results. Genuine pens come from a regulated pharmacy; ours come through official LillyDirect supply, direct from Eli Lilly's UK distribution, and you can check our GPhC registration (9012878) on the public register.¹²

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

12 · NHS and private routes

NHS and private routes to a review

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Either way, the question about tolerance belongs in a review with the person who prescribes. On our service that means ongoing monthly reviews and follow-up assessments by the prescribing team, and side-effect support Monday to Friday.

Many people also use the free GLPTrackr companion app to note doses, symptoms and weight, which gives a prescriber a clearer picture at review. Having a record from the last few months is often more useful than any single figure, and it helps separate a genuine change from a bad week.